Table 1.

Baseline characteristics of patients with axial spondyloarthritis who completed the study as compared to patients who dropped out.

Completer
(n=19)
Non-Completer
(n=57)
p value
Age, years32.5 (7.4)32.8 (8.9)0.91
Male patients, n (%)15 (78.9)29 (50.9)0.034
Symptomduration, years1.1 (1.2)1 (1.7)0.81
HLA-B27 positivity, n (%)18 (94.7)44 (77.2)0.091
Elevated CRP (CRP>5mg/l), n (%)7 (38.9)33 (62.3)0.088
Fulfilled New York criteria, n (%)12 (63.2)27 (47.4)0.24
Patient global (0-10)6.1 (1.9)7.2 (1.7)0.025
Physician global (0-10)5.5 (1.5)6.5 (1.2)0.007
ASDAS3 (0.7)3.5 (0.8)0.042
BASDAI (0-10)5.4 (1.1)5.8 (1.3)0.27
BASFI (0-10)4 (2.1)4.4 (2)0.41
BASMI (0-10)1.2 (1.3)2 (1.6)0.039
AS-QoL (0-18)7.6 (3.9)10.1 (3.9)0.019